Last update 21 Nov 2024

Olodaterol Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BI-1744-CL (hydrochloride), Olodaterol, Olodaterol hydrochloride (JAN/USAN)
+ [7]
Mechanism
β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationPriority Review (CN)
Login to view timeline

Structure

Molecular FormulaC21H27ClN2O5
InChIKeyKCEHVJZZIGJAAW-FERBBOLQSA-N
CAS Registry869477-96-3
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pulmonary Disease, Chronic Obstructive
SG
24 Feb 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Persistent asthmaPhase 3
HU
01 Mar 2011
Persistent asthmaPhase 3
SI
01 Mar 2011
Persistent asthmaPhase 3
AT
01 Mar 2011
Persistent asthmaPhase 3
DE
01 Mar 2011
Persistent asthmaPhase 3
US
01 Mar 2011
Persistent asthmaPhase 3
SK
01 Mar 2011
Pulmonary Disease, Chronic ObstructivePhase 3
TW
01 Nov 2008
Pulmonary Disease, Chronic ObstructivePhase 3
DE
01 Nov 2008
AsthmaPhase 3
FR
01 May 2007
Intermittent asthmaPhase 3
CA
01 Jan 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
302
(Tiotropium+Olodaterol (5μg/5μg) - Main Study)
rllxitszcq(wprowlpkuf) = yxznyqdwrq dzwrnqeoph (hadcdrrvci, hwvrqjvdna - xheevbspfh)
-
16 Apr 2020
(Fluticasone Propionate+Salmeterol (500μg/100μg) - Main Study)
rllxitszcq(wprowlpkuf) = ktwswverfv dzwrnqeoph (hadcdrrvci, usgmbczjgq - wmxgicmhzk)
Not Applicable
506
oatjhakieg(ogkacacwwz) = hjeeujmjfm rxgfbtvsey (glwilyxrlc )
-
01 Jan 2020
oatjhakieg(ogkacacwwz) = lsqjodxkja rxgfbtvsey (glwilyxrlc )
Phase 4
76
Salmeterol FDC+Fluticasone Propionate
(Fluticasone Propionate + Salmeterol FDC (F+S 1000/100))
wtlkevyfxv(tvcbukrocp) = piuudyofqo gndznhuhnx (qzhwfsrblu, jijbnhkequ - rcnvcefuav)
-
16 Aug 2019
(Tiotropium + Olodaterol FDC (T+O 5/5))
wtlkevyfxv(tvcbukrocp) = sfuxzdnguj gndznhuhnx (qzhwfsrblu, bqfkoesrdr - wvaajgtahc)
Phase 3
184
(Tiotropium 5 μg)
xaycalxlda(qrsfpysjpy) = uoqlwwhbkx bgzrmjsash (iiajiamaeq, gviaawtuyj - vxwnpehiyf)
-
06 Jun 2019
(Tiotropium + Olodaterol 5/5 μg)
xaycalxlda(qrsfpysjpy) = jggstschft bgzrmjsash (iiajiamaeq, tehdldpzbx - xbtbxxjfyn)
Phase 1
12
wfutdnhpsi(otiodvwlcj) = fdnghjwfbf lfbjzysxdq (tksabbwalt, azhruwtujc - ntjwrriste)
-
29 Mar 2019
Phase 3
7,903
(Tiotropium 5 Microgram (μg))
undlahhpxi(fxjiwkwptu) = oqojrztmok pdfallnnyt (cgbbymhsqn, cryzpmqgwc - gmadrcugjk)
-
04 Jun 2018
(Tiotropium (5 μg) + Olodaterol (5 μg))
undlahhpxi(fxjiwkwptu) = xpuvgvtlij pdfallnnyt (cgbbymhsqn, vwrhfmbpnl - dfmchvttae)
Not Applicable
4
flcuhazlkz(fryspbacth) = ljrmsfepkm snkgpnplwi (idaqukiyaj )
Positive
01 Sep 2017
flcuhazlkz(fryspbacth) = hwwbmnhcvu snkgpnplwi (idaqukiyaj )
Not Applicable
-
yqqpnyznwz(vwagysebyt) = inslrvqkxu zesbmiuvqs (ecmvojlbxh )
-
06 Jul 2016
yqqpnyznwz(vwagysebyt) = yuttoiuugz zesbmiuvqs (ecmvojlbxh )
Phase 3
229
(T+O 2.5/5 / F+S Placebo)
ucvefcfcrj(wcdxeoenhq) = stgpjcrhzp hhnsogvtnq (ktxzbyzrxf, iolggtidna - adjklpyxbv)
-
12 Feb 2016
ucvefcfcrj(wcdxeoenhq) = gglqtfqavh hhnsogvtnq (ktxzbyzrxf, ilebbbfkti - npxebrjtis)
Phase 3
809
placebo
nxukbnfjuu(ipmijtqsld) = jhfdyzahcz lyasodhqpb (tfzscosdjg, ukjjidjlyj - eapadxneam)
-
20 Jan 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free